The global amniotic membrane market seems to be a very lucrative, attractive, and profitable market, both for existing as well as new entrants. At the same time, intense rivalry among existing competitors has been observed. Our analysis revealed that market players had adopted different strategies to increase their business and position in the global amniotic membrane market. In recent years, strategic movements by major players were product launches, mergers and acquisitions, and expansions, which have been used as market penetration strategies and to reduce competition. The major players in the global amniotic membrane market are MiMedx, Osiris Therapeutics, Integra LifeSciences, Alliqua BioMedical, Inc., Skye Biologics Inc., and others.
Companies are now entering into acquisitions to neutralize growing competition from customers, competitors, and to tackle the changing market dynamics.
Company Share Analysis
There are numerous players operating in this market all over the globe. Most of these players exist in the American and European regions. There are a lot of large and small market players available in the market which provide a wide range of products for various applications. As there are many large and small players in the market, the market shares of these players are very differentiated. Some of the major players who provide amniotic membranes include MiMedx, Applied Biologics, Alliqua BioMedical, Inc., Organogenesis Inc., Integra LifeSciences, Skye Biologics Inc., Amniox Medical, Inc., Katena Products. Inc., Human Regenerative Technologies, LLC, Amnio Technology, LLC, Osiris Therapeutics, and others.
MiMedx, Osiris Therapeutics, Integra LifeSciences, and Alliqua BioMedical, are top players in the global amniotic membrane market, contributing all most 48.7% of the total global market.
Bargaining Power of Suppliers
Bargaining power of suppliers in the global amniotic membrane market is medium. The suppliers in the global amniotic membrane industry are the hospitals and specialty clinics that derive amniotic membrane from the placenta of the fetus. Currently, a moderate number of suppliers are present in the market due to stringent government regulations and high opportunities. Currently, major players are accounting for a significant share of the market. Switching cost of the suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the companies that sell products made using amniotic membranes.
Bargaining Power of Buyers
The bargaining power of the buyers is medium in the global amniotic membrane market due to the presence of a moderate number of providers of amniotic membrane-based products. Also, the market has a large number of buyers comprising hospitals, clinics, ambulatory surgical centers, and other specialty clinics. Also, buyers prefer products manufactured by known brands. However, there are very few big brands present in the market. Because of this, the bargaining power of the buyers is medium.
Threat of New Entrants
The threat of new entrants in the global amniotic membrane market is medium. Any company trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. The market is also characterized by a high degree of brand loyalty where establishing a brand name is difficult for newcomers. Moreover, if a company desires to survive in the market, they have to introduce innovative products for various therapeutic applications and product innovation requires a large amount of investment as well as time. Also, there are very strict government regulations which a company has to follow in the market. However, the presence of huge opportunities in the market has increased the threat of new entrants to the market.
Threat of Substitutes
The threat of substitutes in the global amniotic membrane market is low to medium. Currently, amniotic membranes do not have any direct substitutes. However, stem cell technology can be used in a few of the application areas of amniotic membranes. Hence, the threat of substitutes is low to medium in the amniotic membrane market, due to very less availability of options in the market.
Intense Rivalry
The degree of competition in the global amniotic membrane market is medium. Many companies are present in this market. These players have a moderate degree of product differentiation. They are introducing innovative and more affordable products in the market. These factors slightly increase the rivalry in the amniotic membrane market. Companies involved in amniotic membrane market are trying to acquire new players in the market and merge with major players to survive in the market. Big brands are trying to acquire small players of the market, to create a competitive edge, which is creating a medium level of rivalry in the market.
